Clinical Trials in Houston

Showing 11381-11400 of 17,885 trials

A Novel Catheter Lock Solution for Treatment of Tunneled Hemodialysis Catheter-Associated Bacteremia

NCT00614679

The primary objective is to investigate the ability of systemic intravenous antibiotic plus antibiotic/anti-biofilm (i.e. N-acetylcysteine) lock catheter technique in eradicating uncomplicated catheter associated bacteremia and salvaging the infected vascular catheter. Secondary objectives include duration to clearance of bacteremia, future recurrence of bacteremia, need for catheter removal and death.

End-Stage Renal DiseaseHemodialysis Catheter-associated Infection

University of California, San Diego18 participantsStarted Oct 2006

Houston, Texas, United States • Houston, Texas, United States • Houston, Texas, United States

COMPLETEDPhase 1< 1 mile

MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer

NCT00868595

This is a Phase I, non-randomized, multiple-dose, 3+3 dose-escalation study of the safety, pharmacokinetics, biomarkers, preliminary efficacy and patient-reported outcomes of therapeutic vaccine, BPX-101 (formerly BP-GMAX-CD1), plus activating agent, AP1903, in patients with castrate resistant prostate cancer.

Castrate Resistant Prostate Cancer (CRPC)

Bellicum Pharmaceuticals18 participantsStarted Apr 2009

Houston, Texas, United States

COMPLETEDPhase 2< 1 mile

An Efficacy and Safety Study of Plecanatide in Adolescents 12 to <18 Years of Age With Chronic Idiopathic Constipation

NCT03120520

This is a study of efficacy and safety of Plecanatide in pediatric subjects aged 12 to \< 18 years diagnosed with Chronic Idiopathic Constipation.

Chronic Idiopathic Constipation

Bausch Health Americas, Inc.124 participantsStarted Jan 2017

Foley, Alabama, United States • Jonesboro, Arkansas, United States • Cerritos, California, United States +33 more locations

A Novel Catheter Lock Solution for Treatment of Tunneled Hemodialysis Catheter-Associated Bacteremia

MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer

An Efficacy and Safety Study of Plecanatide in Adolescents 12 to <18 Years of Age With Chronic Idiopathic Constipation

Find Trials by Condition in Houston

Safety and Pharmacokinetics of IGSC 20% in Subjects With Primary Immunodeficiency

Effectiveness of Vitamin D Supplementation

Clinical Evaluation of 3 Contact Lens Materials With 3 Solution Types

A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol

A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR"

An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses

Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers

Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo

Building an Optimal Hand Hygiene Bundle

A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)

ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation

Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis

Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer

Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease

Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing

A Study of Tabalumab (LY2127399) in Participants With Previously Treated Multiple Myeloma (MM)

Novel PI3K Delta Inhibitor TGR-1202, in Combination With Brentuximab Vedotin for Hodgkin's Lymphoma Patients